Abstract
The percentage of dialysis centers that have reported dialyzing human immunodeficiency virus (HIV)-infected patients increased from 11% in 1985 to 37% in 2000. Being primary care physicians for the dialysis patients, nephrologists are frequently confronted with the management of HIV-infected dialysis patients especially in urban centers. The aims of the present review are to discuss issues that are unique to HIV infection and endstage renal disease, and to provide dialysis caretakers with sufficient information to help them optimize care and improve outcomes of these patients. Issues related to the choice of renal replacement therapy, vascular access, management of anemia, vaccination, and antiretroviral therapies are discussed in detail.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 511-521 |
| Number of pages | 11 |
| Journal | American Journal of Nephrology |
| Volume | 24 |
| Issue number | 5 |
| DOIs | |
| State | Published - 2004 |
| Externally published | Yes |
Keywords
- Anemia
- Chronic kidney disease
- Dialysis
- Human immunodeficiency virus
- Vaccination
ASJC Scopus subject areas
- Nephrology